Skip to content

The effect of probiotics in the treatment of infantile colic

Compare the effect of probiotics "(Bifidobacterium Infantis, Lactobacillus Reuteri, Lactobacillus Rhamnosus)" and placebo in the treatment of infantile colic

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016120818971N4
Enrollment
70
Registered
2016-12-27
Start date
2016-12-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infantile colic. Other and unspecified abdominal pain

Interventions

Intervention 1: The first group (interventional group) was given Pedilact with dose 5 drops per day orally for 4 weeks. Intervention 2: The second group (control group) received placebo with dose 5 dr
Treatment - Drugs
The first group (interventional group) was given Pedilact with dose 5 drops per day orally for 4 weeks.
The second group (control group) received placebo with dose 5 drops per day orally for 4 weeks.

Sponsors

Vice chancellor for research, Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
21 Days to 4 Months

Inclusion criteria

Inclusion criteria: The main inclusion criteria include: the infants with crying at least 3 hours a day; for at least 3 days a week; The main exclusion criteria include: the children with organic gastrointestinal disorders; consumption of any antibiotic, probiotics and formula containing probiotics and other madications for colic before entering the study;

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Duration of crying. Timepoint: on days 7, 21 and 30 after initiation of treatment. Method of measurement: Questionnaire.;Crying day in week. Timepoint: on days 7, 21 and 30 after initiation of treatment. Method of measurement: Questionnaire.;Number of crying and irritability attacks per day. Timepoint: on days 7, 21 and 30 after initiation of treatment. Method of measurement: Questionnaire.

Secondary

MeasureTime frame
Vomiting. Timepoint: On days 7, 21 and 30 after initiation of treatment. Method of measurement: Questionnaire.;Constipation. Timepoint: On days 7, 21 and 30 after initiation of treatment. Method of measurement: Questionnaire.;Skin reactions. Timepoint: On days 7, 21 and 30 after initiation of treatment. Method of measurement: Questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactKambiz Eftekhari

Tehran University of Medical Sciences

k-eftekhari@sina.tums.ac.ir+98 21 7301 3210

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026